ONC Q3 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q3 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$220M

Gross Profit

$131M59.3% margin

Operating Income

$115M52.2% margin

Net Income

$117M53.3% margin

EPS (Diluted)

$2.60

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$12M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$285M

Stockholders' Equity

$750M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$220M	$0	—
Gross Profit	$131M	-$30M	+533.8%
Operating Income	$115M	-$35M	+429.9%
Net Income	$117M	-$35M	+430.7%